At Boehringer Ingelheim, we hope to alleviate the burden on people living with serious mental illnesses, their care partners, loved ones, and society. To do this, we have made a long-term commitment to invest in research with the aspiration of redefining mental healthcare in partnership with multiple stakeholders and innovative partners. Our ambition is to create a deeper understanding of the drivers of serious mental illnesses and to provide highly effective therapies for those living with these conditions.

More information about Boehringer Ingelheim can be found at www.boehringer-ingelheim.com.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at www.innovativemedicine.jnj.com/emea/. Follow us at www.linkedin.com/jnj-innovative-medicine-emea

Teva aims to be a new kind of pharmaceutical company, liberated from the traditional definition of a generics company. We harness our generics expertise and innovate, driving the discovery, delivery, and development of modern medicine. We commit to delivering quality medicine, discovering life-changing treatments, and advancing scientific innovation. For us, good is not enough. Our legacy is to be stronger, bolder, and simpler, relentlessly growing by understanding what’s next in science, for patients, people, and society. We are all in for better health. Moving forward together with science that treats, inspired by the people we serve. We are Teva.

More information about Teva can be found at www.tevapharm.com.

For over 150 years, Dr. Willmar Schwabe Pharmaceuticals has led the way in phytopharmaceuticals. Our products are the result of years of cutting-edge research and experience, and their high quality and clinical evidence for special extracts guarantee consistent efficacy, high safety, and good tolerability. With a global workforce of over 3,500 individuals spanning five continents, we are dedicated to our philosophy: “You and your health are central”. That’s why our products are meticulously tailored to your specific health needs.

More information about Dr. Willmar Schwabe GmbH & Co. KG can be found at www.schwabe-group.com/en.

Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ™ (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients.

More information about Indorsia can be found at www.idorsia.com.

Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: ‘Otsuka – people creating new products for better health worldwide.’ Our 34,400 employees channel their passion and commitment into aiming to improve the health of our patients, with a focus in Europe on therapies in mental health, nephrology, haemato-oncology, rare diseases and digital therapeutics.

More information about Otsuka Pharmaceutical can be found at www.otsuka-europe.com.

Recordati is an international pharmaceutical group dedicated to the research, development, manufacturing and marketing of innovative medicines to achieve our purpose: improve people’s health and quality of life. We offer high-quality accessible products in various therapeutic areas through our Specialty & Primary Care business, and our Rare Diseases business provides treatments for serious unmet medical needs.​​​​​​​ Headquartered in Hungary, Gedeon Richter is an innovation-driven specialty pharmaceutical company, boasting the biggest pharmaceutical research centre in Central Europe. One of its latest achievements is the original antipsychotic, cariprazine, marketed in the US for BD, schizophrenia and aMDD treatment, and in most European countries, for the treatment of schizophrenia in adult patients.

More information about Recordati and Gedeon Richter can be found at www.recordati.com/it/ and www.gedeonrichter.com/en.

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.

More information about Biogen can be found at www.biogen.com.

ROVI is a pan-European pharmaceutical company that specialises and engages in the research, development, contract manufacturing and licensing of small molecules and biological specialties. The company, in a continuous expansion process, has subsidiaries in Portugal, Germany, the United Kingdom, Italy, France and Poland and has a diversified marketing portfolio of over 40 products, among which its flagship product, bemiparin, now present in more than 60 countries all over the world, should be highlighted. Likewise, ROVI markets its enoxaparin biosimilar, developed inhouse, in Europe and this product is already present in 40 countries. ROVI is continuing to develop the ISM® technology platform, a leading-edge line of research in the field of prolonged drug release, with proven advantages.

More information about ROVI can be found at www.rovi.es/en/.

Viatris is global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life’s moments, from birth to the end of life, acute conditions to chronic diseases.

More information about Viatris can be found at www.viatris.com/en.

ADAMED is an international laboratory specialized in specialists. With a young and dynamic style, we offer new solutions tailored to the daily needs of specialists. Our global presence is backed by a strong position in R&D, fully committed to innovation, quality, and service, dedicating ourselves to our work with heart and mind.

More information about ADAMED can be found at www.adamed.com/en/main-page.

AliveCor revolutionises heart care with intelligent, personalised heart data for clinicians and patients, available anytime, anywhere. KardiaMobile 6L, the world’s first FDA-cleared six-lead personal ECG, provides accurate readings in 30 seconds, detecting six common arrhythmias. Patients can monitor their heart health at home, sharing real-time data with healthcare providers. AliveCor’s SDK and API solutions enable seamless integration of Kardia technology into clinical platforms. The InstantQT point-of-care solution offers fast QT measurements*, supporting safer use of antipsychotic medications. AliveCor enhances accessibility, fosters trust, and delivers actionable insights to transform global cardiovascular care.

*QT measurements made using the EK12 ECG algorithm from GE

More information about AliveCor can be found at www.alivecor.co.uk.

Bologna Health Jobs is a partner of the HSE , it is one of the Ireland’s leading healthcare provider’s based in Dublin (Ireland) with international coordinators in several European countries. The agency currently places doctors of all specialties in locum and contract positions. We understand the needs of our clients and candidates so we try to help them as best we can in an honest way. We understand that for doctors that are thinking to relocate to a new country many questions can arise so we try to help as best we can in many issues as can be getting registered with the Irish Medical Council (IMC), career planning in Ireland, Tax advice, getting your experience recognized in the country, etc. We actually pride ourselves with having long lasting relationships with the doctors we place so we will typically stay in touch for years with those doctors that we place.

More information about Bologna Health Jobs can be found at www.bolognahealthjobs.com.

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. We are boldly advancing neuroscience with our proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder (OCD), and smoking addiction. We are dedicated to leading through superior science and building on our unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. BrainsWay is dual-listed on the NASDAQ and Tel Aviv Stock Exchange (TASE).

More information about BrainsWay can be found at www.brainsway.com.

Cambridge University Press is a not-for-profit publisher that dates from 1534 and is part of the University of Cambridge. Our mission is to unlock people’s potential with the best learning and research solutions by combining state-of-the-art content with the highest standards of scholarship, writing and production. Visit our stand to discuss publishing with us and browse our latest publications. Books available to purchase online with a 30% discount in link below.

More information about Cambridge University Press can be found at www.cambridge.org/epa2025.

CEREBRUM VR provides cutting-edge, scientifically-driven solutions designed to enhance mental health and well-being. At the heart of our work lies the creation, testing, and development of immersive Virtual Reality technologies tailored for psychiatric rehabilitation, neuropsychological treatments, psychological support, and psychotherapeutic interventions. Our mission is simple: to make therapies more effective and ultimately elevate patients’ quality of life.

More information about CEREBRUM VR can be found at www.cerebrumvr.com.

DEYMED Diagnostic is a leading Czech company with an established global existence, specialising in advanced medical diagnostic and treatment technologies for neurophysiology and psychiatry. Founded in 1997, DEYMED has expanded its product range over the years to include EEG, EMG, TMS (Transcranial Magnetic Stimulation), PSG (Polysomnography), and BFB (Biofeedback) systems, trusted by healthcare providers worldwide for their precision, reliability, and ease of use.

More information about DEYMED Diagnostic can be found at www.deymed.com.

ECNP is Europe’s leading independent forum for the science of CNS treatments. The ECNP Congress showcases the world’s best disease-oriented brain research, annually attracting nearly 7,000 psychiatrists, neuroscientists, neurologists and psychologists. ECNP’s wide range of scientific and educational activities, programmes and events make it the largest non-institutional supporter of applied and translational neuroscience research and education in Europe.

More information about ECNP can be found at www.ecnp.eu/Congress2025/ECNPcongress.

Edra offers a comprehensive solution combining two tools to provide periodic and longitudinal monitoring for comprehensive and personalized care of patients with depressive and bipolar disorders. Through a remote monitoring platform, healthcare professionals can evaluate the effectiveness of treatments and improve the follow-up and care of their patients. Thanks to an app, patients can measure their symptoms and access resources to better understand and manage the manifestations of their disorders, and thus improve their well-being.

More information about Edra can be found at www.edra.care/en.

EPI is a global medical device company improving lives through unique neuromodulation therapeutics. We develop and manufacture the Alpha-Stim® brand of patented, non-invasive devices that provide fast, safe, and highly effective treatment for anxiety, insomnia, depression, and pain. Proven through extensive clinical research, Alpha-Stim is available over the counter in dozens of countries worldwide, though it requires a prescription in the US. EPI’s subsidiary, Pulvinar Neuro, leads our research into promising emerging non-invasive brain stimulation technology. Presently, it is developing closed-loop transcranial alternating current stimulation (tACS) for the treatment of certain psychiatric disorders.

More information about EPI can be found at www.epii.com.

EUFAMI, founded in 1992, is a democratic, international non-profit organisation based in Belgium, committed to improving the care and welfare of people affected by mental ill health. It advocates for the rights of family carers to be recognised as equal partners in care decisions and for equitable mental health services across Europe. EUFAMI supports member associations, promotes best practices, and lobbies policymakers to ensure adequate resources and non-discriminatory policies. Its vision is a society where people with mental ill health and their families are fully included, enjoying the same social, economic, and political rights as others without discrimination.

More information about EUFAMI and be found at www.eufami.org.

The European Academy of Neurology (EAN) is a non-profit, independent organisation representing more than 45,000 members and 48 European national societies. As Europe’s ‘Home of Neurology’, our mission is to foster and support the development of neurological excellence in Europe and across the world, leading to better patient care and outcomes. With 32 Scientific and Coordinating Panels composed of experts on a range of neurological specialties, we aim to promote quality in neurology and bring together Europe’s best clinicians, educators, and scientists in the field to achieve our mission. We also aim to keep Europe at the forefront of neurological research and maintain its position as one of the world’s scientific hotspots in neurology.

More information about The European Academy of Neurology can be found at www.ean.org.

A non-profit organisation based in Brussels, its main mission is to promote brain research with the ultimate goal of improving the lives of the estimated 179 million Europeans living with brain conditions. With the aim to speak with one voice, EBC stands as the platform to foster cooperation between its member organisations and other stakeholders, consistently promoting dialogue between scientists, industry and society.

More information about European Brain Council can be found at www.braincouncil.eu/.

The European Federation of Psychiatric Trainees (EFPT) is a dynamic organization dedicated to connecting, engaging, representing, and empowering psychiatric trainees across Europe. Comprising passionate trainees and young psychiatrists, EFPT facilitates collaboration, education, and advocacy within the field. Through its working groups and active members, EFPT encourages trainees to excel in their careers while advocating for the highest standards of mental healthcare. With a commitment to inclusivity and diversity, EFPT fosters a supportive community where members can exchange ideas, gain valuable skills, and contribute to shaping the future of psychiatry in Europe.

More information about EFPT can be found on our website https://efpt.eu/.

With active individual members in as many as 88 countries and 44 National Psychiatric Association Members who represent more than 78 000 European psychiatrists, the European Psychiatric Association is the main association representing psychiatry in Europe. The EPA’s activities address the interests of psychiatrists in academia, research and practice throughout all stages of career development.

The EPA deals with psychiatry and its related disciplines and focuses on the improvement of care for the mentally ill as well as on the development of professional excellence.

More information about the European Psychiatric Association can be found at www.europsy.net.

Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (~1,200 patents) in joint care, skin care, eye care, aesthetic care, specialty care and regenerative care. Manufacturing operations – located in Italy – are inspected and approved by major international health authorities, including the US FDA, and comply with the strictest international regulations and safety standards. Fidia extends its global reach through local partners in +120 countries worldwide, as well as wholly owned subsidiaries in USA, Germany, Austria, Spain, France, Russia, Czech Republic, Slovakia, Romania, Poland, Egypt and Middle East.

More information about Fidia Farmaceutici S.p.a can be found at www.fidiapharma.com.

Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe) is a non-profit, patient-driven pan-European organisation representing and advocating for the interests and rights of people affected by mental illness. Its principal activities include advocacy, information, awareness-raising, education, partnership, and capacity building. Our work’s overarching themes include destigmatising mental illness and championing patients’ rights.

More information about GAMBIAN-Europe can be found at www.gamian.eu.

For more than four decades we’ve been advancing what’s possible at the point of care.​ Our caring commitment to our people, partners and patients remains as strong as it was on the first day of our journey. We provide foundational diagnostic solutions that enable high-quality care across clinical settings and geographies.

Standing on time tested expertise we work in close collaboration with stakeholders across the healthcare industry to transform diagnostics data into insights that enhance global health.
Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

More information about HemoCue can be found at www.hemocue.com/en/.

Pioneers in Light Therapy

In 2006, we were the first to come up with a wearable light therapy device that could be integrated into your morning routine. 4 years of research at the University of Liège in Belgium led to the creation of the first light therapy glasses, combining effectiveness and ease of use. The effectiveness of a light therapy lamp depends on the regularity with which it is used. In practice, it is difficult to sit in front of a light therapy lamp for 30 minutes every day. Thanks to the Luminette, you will be able to do your light therapy session while remaining active and light therapy will not be a constraint. You will therefore have a better chance of feeling the positive effects of light on your energy level and the quality of your sleep.

More information about Lucimed can be found at www.myluminette.com.

MagVenture is a market-leading manufacturer of non-invasive Transcranial Magnetic Stimulation (TMS) and Magnetic Peripheral Nerve Stimulation (mPNS) systems. Privately-owned and headquartered in Denmark, MagVenture has been pioneering cutting-edge magnetic stimulation solutions for more than 30 years. MagVenture’s TMS and mPNS systems are used for a wide range of applications in both research and treatment in the fields of psychiatry, neurophysiology, neurology, cognitive neuroscience, and rehabilitation. MagVenture’s vision is to offer new hope to patients by transforming how mental health and physical conditions are treated. Our mission is to pioneer safe, effective, and reliable magnetic stimulation therapies, offer innovative and versatile research solutions and work to expand access to magnetic stimulation worldwide. MagVenture’s products are available on the global market through direct sales subsidiaries in the USA, Germany, the UK, China, and Brazil, and through a global network of distributors.

More information on MagVenture can be found at www.magventure.com/en_eur/.

MatchMedics is Ireland’s top medical recruitment agency, specializing in Psychiatrists, GPs, and all specialties for doctors seeking new career opportunities. Ireland offers some of the highest Consultant salaries in the EU, ranging from €231,214 to €277,736, with a balanced 37-hour workweek. Enjoy a thriving career while experiencing Ireland’s stunning landscapes, vibrant culture, and world-famous scenery. With roles available nationwide, now is the perfect time to advance your career in a country that values both professional growth and quality of life. Take the next step—make Ireland your destination for success and a fulfilling lifestyle!

More information about MatchMedics can be found at www.matchmedics.com.

neurocare group AG offers a best practice mental health platform, enabling clinicians to provide personalized therapy for psychological and neurological conditions with sustainable outcomes. Therapy plans integrate psychotherapy, neuromodulation, sleep hygiene, and medication. Following a detailed assessment, we support clinicians in enhancing self-regulation, resilience, and social skills cost-effectively. The platform includes in-house-developed technology for non-invasive brain stimulation via TMS (transcranial magnetic stimulation) and tDCS (transcranial direct current stimulation), neurofeedback, QEEG, a cloud-based software, as well as an online academy for detailed training of all modalities. Our solutions are used in our clinics in Europe, the US, and Australia, as well as in a growing number of third-party clinics. Visit our booth to discuss your requirements with us, to learn how you can enhance your therapy outcomes with state-of-the-art neuromodulation or discuss your options for joining our clinics network.

More information about neurocare group AG can be found at www.neurocaregroup.com.

At Neurotorium.org, our mission is to improve awareness and knowledge of the brain and its diseases. We provide unbiased and freely available, online educational content created for clinicians, educators and all who are interested in learning more about the brain. All our educational material is developed, reviewed, and regularly updated by leading experts within the fields of psychiatry, neurology, and neuroscience. Neurotorium.org is a non-commercial, non-profit initiative founded by the Lundbeck Foundation.

More information on Neurotorium can be found at www.neurotorium.org.

Since its inception in 1989, Northern Lights are top of the line Bright Light Therapy manufacturers in Canada. Emerging as one of the most significant light therapy experts, involved in handfuls of clinical studies, Northern Lights products offer 10,000 Lux of white light to mimic the vibrant clarity of a spring day. Built as beacons to help reverse the effects of Seasonal Affective Disorder (SAD), as well as some sleep disorders like DSPS. Bright Light has since proven it’s effectiveness in parkinsons, major depression, parinatal depression and alzheimers and many others mainly by helping to regulate the circadian rhythm. Still built in Canada today, NLTs Bright Lights are beacons of hope for hundreds of thousands of its clientele. Endorsed by the world’s leading authorities and clinicians.

More information about Nothern Light Technologies can be found at northernlighttechnologies.com.

Saladax Biomedical, Inc. offers rapid, precise therapeutic drug monitoring assays for psychiatric medications, for both clinical laboratories and at the point-of-care. Our MyCare™ Psychiatry assays provide quantitative insights for optimizing patient care. Revolutionizing psychiatric care, the MyCare Insite is a groundbreaking point-of-care device to measure clozapine and total aripiprazole, enabling real-time decision-making during patient consultations.

More information about Saladax Biomedical Inc. can be found at www.mycaretests.com.

Based in Switzerland, STORZ MEDICAL develops innovative shock wave systems for extracorporeal treatment of kidney stones since late 1980s. Today, we employ shock waves in the treatment of musculoskeletal disorders, pseudarthrosis and angina pectoris. In the 1990s, we discovered the effectiveness of shock waves in the treatment of peripheral neurological diseases such as post-traumatic spasms and polyneuropathy. The first treatment of Alzheimer’s patients with shock waves was in 2014. In 2018, Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system was the first of its kind to obtain authorization for the treatment of the central nervous system of Alzheimer’s patients. Resulting from this success, neurological diseases such as Parkinson, stroke and spinal cord injuries are a focus in our development activities.

More information about STORZ MEDICAL AG can be found at www.storzmedical.com

Wisepress.com, Europe’s leading conference bookseller, attend around 200 conferences every year. We have an extensive range of books and journals relevant to the themes of this conference available at our booth. We also have a comprehensive range of STM titles available on our online bookshop.

More information about Wisepress can be found at www.wisepress.com.

Yingchi Technology is based in Shenzhen, China, specializing in the research and application of advanced technologies for diagnosing and treating brain and neurological diseases. Established in 2012, it is a high-tech enterprise with a strong R&D team dedicated to improving healthcare and patient outcomes. Ionclinics is a leading medical device company focused on non-invasive therapies for neurological conditions. Their team integrates medical and technical expertise to create innovative, user-friendly, and safe products that enhance patients’ quality of life.

More information about YINGCHI – IONCLINICS can be found at www.yingchitech.com/en.